-
Abstract Number: PB0343
N-Acetyl Cysteine Prevents Occlusive Arterial Thrombosis in a Dose-Dependent Manner
-
Abstract Number: OC 04.3
N-glycan-mediated shielding of ADAMTS13 effectively prevents binding of pathogenic autoantibodies in high-titer patients with immune-mediated Thrombotic Thrombocytopenic Purpura
-
Abstract Number: OC 77.2
Na+/K+ ATPase alpha 1 subunit participates in platelet signaling and is a potential anti-thrombotic target
-
Abstract Number: OC 61.5
National Incidence of Bleeding-Related Hospitalisations and Mortality by Anatomical and ISTH site classification in England 2014-2019
-
Abstract Number: PB0981
Nationwide analysis of Pre-Hospital Tranexamic Acid in trauma patients at risk of bleeding
-
Abstract Number: PB0053
NET formation in patients with COVID-19 and non-COVID-19 ARDS on venovenous ECMO
-
Abstract Number: PB0745
NETosis in Sickle Cell Anemia
-
Abstract Number: PB1400
Neurologically asymptomatic patients with pure obstetric antiphospholipid syndrome cumulate progressive microstructural brain damages, mild functional abnormalities, and subtle cognitive impairments
-
Abstract Number: PB0008
Neutralizing anti-emicizumab antibodies in a patient with Acquired Hemophilia A
-
Abstract Number: PB0221
Neutralizing antidrug antibody to emicizumab: Detailed laboratory evaluation and review of the literature
-
Abstract Number: PB0731
Neutrophil activation markers as novel biomarkers for advanced stages of high-grade serous ovarian cancer
-
Abstract Number: OC 46.2
Neutrophil Cathepsin G Cleaves Fibrinogen Affecting Clot Structure
-
Abstract Number: OC 68.5
Neutrophil Extracellular Traps as a Mediator of Cerebral Ischemia and Reperfusion Injury in Ischemic Stroke
-
Abstract Number: OC 20.1
Neutrophil Extracellular Traps promote joint injury in hemophilia
-
Abstract Number: OC 38.2
Neutrophils and platelets collaborate to induce an increase NET formation during JAK2V617F positive myeloproliferative neoplasms
-
Abstract Number: OC 72.2
Neutrophils protect against Staphylococcus aureus endocarditis but the impact of NET release is negated by coagulases
-
Abstract Number: PB0371
New experimental evidence for a role of platelets in cholesterol-induced vascular and valvular calcification
-
Abstract Number: VPB1168
New Technologies such as Virtual Reality to increase Adherence in Hemophilia Treatment
-
Abstract Number: PB1059
Next-generation FVIII mimetic, Mim8, does not interfere with non-factor VIII haemostasis assays.
-
Abstract Number: VPB0109
NLRP3 inflammasome activation and immunothrombosis in COVID-19.
-
Abstract Number: VPB0696
No difference in the management of Covid-19 hemophilic and non-hemophilic patients
-
Abstract Number: PB0441
No pharmacological effect of the P-glycoprotein inhibitor tamoxifen on edoxaban plasma levels in patients with breast cancer: the PHIX-IT study
-
Abstract Number: OC 45.3
Non-invasive In Vivo Thrombus Imaging in Patients with Ischaemic Stroke or Transient Ischaemic Attack.
-
Abstract Number: VPB1350
Non-O Blood Type is Risk Factor for Venous Thromboembolism in Acutely Injured Patients Requiring Orthopaedic Surgery
-
Abstract Number: PB1281
Non-parenchymal origin of alternatively spliced tissue factor in chronic liver disease
-
Abstract Number: PB1175
Norwegian Real-World Experience with recombinant factor IX Fc (rFIXFc) in Haemophilia B (HB) Patients
-
Abstract Number: PB1176
Norwegian Real-World Experience with recombinant factor VIII Fc (rFVIIIFc) in Haemophilia A (HA) Patients
-
Abstract Number: PB1127
Novel accreditation of European haemophilia treatment and gene therapy centres
-
Abstract Number: OC 26.3
Novel Flow Cytometric Diagnostic Assay for Primary Immune Thrombocytopenia.
-
Abstract Number: OC 64.3
Novel GNE gene variants associated with severe congenital thrombocytopenia and platelet sialylation defect – follow up data after hematopoietic stem cell transplantation
-
Abstract Number: PB1185
Novel miniaturized Chemiluminescent-based Factor VIII activity assay
-
Abstract Number: PB1234
Novel Pathological GATA1 Variant Leads to Defective Platelet Biogenesis via Impaired Transcriptional Regulation
-
Abstract Number: OC 59.4
Novel variants in GALE caused syndromic macrothrombocytopenia disrupting thrombopoiesis and glycosylation
ISTH 2022 Congress
July 9-13, 2022. London, England, UK.